Neurovirulence of influenza A virus

Journal of NeuroVirology

Volumn 2, Issue 3, 1996, Pages 139-151

  Ward, Auster C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

HA cleavage; HA gene; M gene; NA gene; Neurovirulence; NS gene; Splicing control; Virus adaptation

Indexed keywords

HEMAGGLUTININ; MATRIX PROTEIN; MESSENGER RNA; MUTANT PROTEIN; RIBONUCLEOPROTEIN; SIALIDASE;

ADAPTATION; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; RNA SPLICING; RNA STRUCTURE; VIRUS GENE; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALIA; INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 0030018612     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289609146876     Document Type: Review

References (122)

1. Anders EM, Hartley CA, Jackson DA (1990). Bovine and mouse serum inhibitors of influenza A viruses are mannose-binding lectins. Proc Natl Acad Sci USA 87: 4485-4489.
2. Anders EM, Hartley CA, Reading PC, Ezekowitz RAB (1994). Complement-dependent neutralisation of influenza virus by serum mannose-binding lectin. J Gen Virol 75: 615-622.
3. Armstrong CL, Miranda AF, Hsu KC, Gamboa ET (1978). Susceptibility of human skeletal muscle culture to influenza virus infection. I. Cytopathology and immunofluorescence. J Neurol Sci 35: 43-57.
4. Baez M, Palese P, Kilbourne ED (1980). Gene composition of high-yielding influenza vaccine strains obtained by recombination. J Infect Dis 141: 362-369.
5. Bonin J, Scholtissek C (1983). Mouse neurotropic recombinants of influenza A viruses. Arch Virol 75: 255-268.
6. Bosch FX, Garten W, Klenk HD, Rott R (1981). Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of avian influenza viruses. Virology 113: 725-735.
7. Bradshaw GL, Schlesinger RW, Schwartz CD (1989a). Effects of cell differentiation on replication of A/WS/ 33, WSN, and A/PR/8/34 influenza viruses in mouse brain cell cultures: biological and immunological characterization of products. J Virol 63: 1704-1714.
8. Bradshaw GL, Schwartz CD, Husak PJ, Schlesinger RW (1989b). Expression of influenza gene segments 7 and 8 in cultured mouse brain cells varies according to cell type and virus strain, in correlation with ratios spliced/full-length mRNAs. In: Genetics and Pathogenicity of Negative Strand Viruses. Kolakofski D, Mahy BWJ (eds). pp. 379-386. Elsevier Science Publishers: Amsterdam.
9. Bradshaw GL, Schwartz CD, Schlesinger RW (1990). Replication of H1N1 influenza viruses in cultured mouse embryo brain cells: virus strain and cell differentiation affect synthesis of proteins encoded in RNA segments 7 and 8 and efficiency of mRNA splicing. Virology 176: 390-402.
10. Brown EG (1990). Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7 and 8. J Virol 64: 4523-4533.
11. Burnet FM (1948). Mucins and mucoids in relation to influenza virus action. IV. Inhibition by purified mucoid of infection and haemagglutinin with the virus strain WSE. Aust J Exp Biol Med Sci 26: 381-387.
12. Burnet FM (1951). A genetic approach to variation in influenza viruses. 1. The characters of three substrains of influenza virus A (WS). J Gen Microbiol 5: 46-53.
13. Burnet FM, McCrea JF, Anderson SG (1947). Mucin as a substrate of enzyme action by viruses of the mumps influenza group. Nature 160: 404-405.
14. Colman PM (1989). Neuraminidase enzyme and antigen. In: The Influenza Viruses. Krug RM (ed). pp. 175-218. Plenum Press: New York.
15. Conti G, Vakavi P, Natali A, Schilto GC (1980). Different patterns of replication in influenza virus-infected KB cells. Arch Virol 66: 309-320.
16. Daniels RS, Downie JC, Hay AJ, Knossow M, Skehel JJ, Wang ML, Wiley DC (1985). Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell 40: 431-439.
17. Edelen JS, Bender TR, Chin TDY (1974). Encephalopathy and pericarditis during an outbreak of influenza. Am J Epidemiol 100: 79-84.
18. Enami K, Sato TA, Nakada S, Enami M (1994). Influenza virus NS1 protein stimulates translation of the Ml protein. J Virol 68: 1432-1437.
19. Francis T, Moore AE (1940). A study on the neurotropic tendency in strains of the virus of epidemic influenza. J Exp Med 72: 717-728.
20. Franková V, Jirásek A, Tumov B (1977). Type A influenza: Postmortem virus isolations from different organs in human lethal cases. Arch Virol 53: 265-268.
21. Fraser KB, Nairn RC, McEntegart MG, Chadwick CS (1959). Neurotropic and non-neurotropic influenza A infection of mouse brain studied with fluorescent antibody. J Pathol Bact 78: 423-433.
22. Gamboa ET, Harter DH, Wolf A, Benitez H, Takahata N, Duffy P, Hsu K (1974). Replication of neurotropic influenza virus in organotypic cultures of embryonic mouse hypothalamus. J Neuropathol Exp Neurol 33: 571-581.
23. Ghendon Y, Tukova E, Vonka V, Klimov A, Ginzburg V, Markushin S (1979). Replication of two influenza virus strains and a recombinant in HEF and CEP cells. J Gen Virol 44: 179-186.
24. Giesendorf B, Bosch FX, Wahn K, Rott R (1984). Temperature sensitivity in maturation of mammalian influenza A viruses. Virus Res 1: 655-667.
25. Gitelman AK, Kaverin NV, Kharitonenkov IG, Rudneva IA, Sklyanskaya EL, Zhdanov VM (1986). Dissociation of the haemagglutination inhibition and the infectivity neutralisation in the reactions of influenza A/USSR/ 90/77 (H1N1) virus variants with monoclonal antibodies. J Gen Virol 67: 2247-2251.
26. Gottschalk A (1957). Neuraminidase: specific enzyme of influenza virus and Vibrio cholerae. Biochim Biophys Acta 23: 645-646.
27. Gregoriades A, Frangione B (1981). Insertion of influenza M protein into the viral lipid bilayer and localisation of site of insertion. J Virol 40: 323-328.
28. Gujuluva CN, Kundu A, Murti KG, Nayak DP (1994). Abortive replication of influenza virus A/WSN/33 in HeLa229 cells: defective viral entry and budding process. Virology 204: 491-505.
29. Hankins RW, Nagata K, Bucher DJ, Popple S, Ishihama A (1989). Monoclonal antibody analysis of influenza virus matrix protein epitopes involved in transcription inhibition. Virus Genes 3: 111-126.
30. Hartley CA, Jackson DC, Anders EM (1992). Two distinct mannose-binding lectins function as inhibitors of influenza virus: identification of bovine serum inhibitor as conglutinin. J Virol 66: 4358-4363.
31. Hatada E, Hasegawa M, Shimizu K, Hatanaka M, Fukuda R (1990). Analysis of influenza A virus ts mutants with mutations in RNA segment 8. J Gen Virol 71: 1283-1292.
32. Hatada E, Takizawa T, Fukuda R (1992). Specific binding of influenza A virus NS1 protein to virus minus-sense RNA in vitro. J Gen Virol 73: 17-25.
33. Helenius A (1992). Unpacking the incoming influenza virus. Cell, 69: 577-578.
34. Hiti AL, Davis AR, Nayak DP (1981). Complete sequence analysis shows that the hemagglutinins of the H0 and H2 subtypes of human influenza virus are closely related. Virology 111: 113-124.
35. Hobson N, Flockton HI, Gould EA (1968). The inhibitor-destroying activity of influenza virus strains of differing neurovirulence for mice. J Gen Virol 3: 445-448.
36. Homer FA (1958). Neurologic disorders after Asian influenza. N Engl J Med 258: 983-985.
37. Huang T-S, Palese P, Krystal M (1990). Determination of influenza virus proteins required for genome replication. J Virol 64: 5669-5673.
38. Inglis SC, Brown CM (1984). Differences in the control of virus mRNA splicing during permissive or abortive infection with influenza A (fowl plague) virus. J Gen Virol 65: 153-164.
39. Johnson KP, Johnson RT (1972). Granular ependymitis. Occurrence in myxovirus infected rodents and prevalence in man. Am J Pathol 67: 511-524.
40. Jungherr EL, Tryzzer EE, Brandley CA, Moses HE (1946). The comparative pathology of fowl plague and newcastle disease. Amer J Vet Res 7: 250-288.
41. Kaverin NV, Finskaya NN, Rudneva IA, Gitelman AK, Kharitonenkov IG, Smirnov YA (1989). Studies on the genetic basis of human influenza A virus adaptation to growth in mice: degrees of virulence of reassortants with defined genetic content. Arch Virol 105: 29-37.
42. Kawano H, Rostaphsov V, Rosen L, Lai CJ (1993). Genetic determinants of dengue type 4 virus neurovirulence for mice. J Virol 67: 6567-6575.
43. Kawaoka Y, Naeve CW, Webster RG (1984). Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology 139: 303-316.
44. Kilbourne ED (1963). Influenza virus genetics. Progr Med Virol 5: 79-126.
45. Kilbourne ED (1987). Influenza. Plenum Press: New York.
46. Kilbourne ED, Sugiura A, Wong SC (1964). Serial multiplication of an influenza A virus (NWS) in certain human diploid cell strain. Proc Soc Exp Biol Med 116 225-228.
47. Klenk HD, Rott R, Orlich M, Blodorn J (1975). Activation of influenza A viruses by trypsin treatment. Virology 68: 426-439.
48. Klimov AI, Sokolov NI, Orlova NG, Ginzburg VP (1991). Correlation of amino acid residues in the Ml and M2 proteins of influenza virus with high yielding properties. Virus Res 19: 105-114.
49. Kohn DF, Chinookoswong N, Magill LS (1981). Pathogenicity of influenza A virus in ependymal organ culture. Teratology 24: 201-213.
50. Kristensson K, Norrby E (1986). Persistance of RNA viruses in the central nervous system. Annu Rev Microbiol 40: 159-184.
51. Krug RM, Alonso-Caplen FV, Julkunen I, Katze MG (1989). Expression and replication of the influenza virus genome. In: The Influenza Viruses. Krug RM (ed). pp. 89-152. Plenum Press: New York.
52. Lamb RA (1989). Genes and proteins of influenza virus. In: The Influenza Viruses. Krug RM (ed). pp. 1-87. Plenum Press: New York.
53. Lamb RA, Lai CJ (1982). Spliced and unspliced messanger RNAs synthesized from cloned influenza virus M DNA in an SV40 vector: expression of the influenza virus membrane protein. Virology 123: 237-256.
54. Lazarowitz SG, Choppin PW (1975). Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology 68: 440-454.
55. Lazarowitz SG, Compans RW, Choppin PW (1971). Influenza virus structural and non-structural proteins in infected cells and their plasma membranes. Virology 46: 830-843.
56. Lazarowitz SG, Goldberg AR, Choppin PW (1973). Proteolytic cleavage by plasmin of the hemagglutinin polypeptide of influenza virus. Host cell activation of serum plasminogen. Virology 56: 172-180.
57. Levine B, Griffin DE (1993). Molecular analysis of neurovirulent strains of Sindbis virus that evolve during persistent infection of scid mice. J Virol 67: 6872-6875.
58. Li S, Orlich M, Rott R (1990). Generation of influenza virus variants pathogenic for chickens because of hemagglutinin cleavage site changes. J Virol 64: 3297-3303.
59. Li S, Schulman J, Hamura S, Palese P (1993). Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. J Virol 67: 6667-6673.
60. Lohmeyer J, Talens LT, Klenk HD (1979). Biosynthesis of the influenza virus envelope in abortive infection. J Gen Virol 42: 73-88.
61. Martin K, Helenius A (1991). Nuclear transport of influenza virus ribonucleoproteins, the viral matrix protein (M1) promotes export and inhibits import. Cell 67: 117-130.
62. Mayer V, Schulman JL, Kilbourne ED (1973). Non-linkage of neurovirulence exclusively to viral hemagglutinin or neuraminidase in genetic recombinants of A/NWS (H0N1) influenza virus. J Virol 11: 272-278.
63. Mims CA (1960). An analysis of the toxicity for mice of influenza virus. I. Intracerebral toxicity. Br J Exp Pathol 41: 586-592.
64. Miyoshi K, Wolf A, Harter DH, Duffy PE, Gamboa ET, Hsu KC (1973). Murine influenza virus encephalomyelitis. I. Neuropathological and immunofluorescence findings. J Neuropathol Exp Neurol 32: 51-71.
65. Murphy AM, Hawkes RA (1970). Neurological complications of influenza A2/Hong Kong/68 virus. Med J Aust 2: 511.
66. Murphy BR, Webster RG (1990). Orthomyxoviruses. In: Virology. Fields BN, Knipe DM (eds). pp. 1091-1152. Raven Press Ltd: New York.
67. Nakajima S, Sugiura A (1980). Neurovirulence of influenza virus in mice. II. Mechanism of virulence as studied in a neuroblastoma cell line. Virology 101: 450-457.
68. Odagiri T, Tobita K (1990). Mutation in NS2, a nonstructural protein of influenza A virus, extragenetically causes aberrant replication and expression of the PA gene and leads to the generation of defective interfering particles. Proc Natl Acad Sci USA 87: 5988-5992.
69. Palese P, Tobita K, Ueda M, Compans RW (1974). Characterisation of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61: 397-410.
70. Ravenholt RT, Foege WH (1982). 1918 Influenza, encephalitis lethargica, Parkinsonism. Lancet 2: 860-864.
71. Richardson JC, Akkina RK (1991). NS2 protein of influenza virus is found in purified virus and phosphorylated in infected cells. Arch Virol 116: 69-80.
72. Rogers GN, Paulson JC, Daniels RS, Skehel JJ, Wilson IA, Wiley DC (1983). Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 304: 76-78.
73. Rose E, Prabhakar P (1982). Influenza A virus associated neurological disorders in Jamaica. W I Med J 31: 29-33.
74. Rott R, Orlich M, Klenk HD, Wang ML, Skehel JJ, Wiley DC (1984). Studies on the adaptation of influenza viruses to MDCK cells. EMBO J 3: 3329-3332.
75. Ruigrok RWH, Aitkin A, Calder LJ, Martin SR, Skehel JJ, Wharton SA, Weis W, Wiley DC (1989a). Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion. J Gen Virol 69: 2785-2795.
76. Ruigrok RWH, Calder LJ, Wharton SA (1989b). Electron microscopy of the influenza virus submembrane structure. Virology 173: 311-316.
77. Schäfer W (1955). Vergleichende sero-immunologische Untersuchungen über die Viren der Influenza and klassischen Geflügelpest. Z Naturf 10b: 81-91.
78. Scheiblauer H, Kendal AP, Rott R (1995). Pathogenicity of influenza A/Seal/Mass/1/80 virus mutants for mammalian species. Arch Virol 140: 341-348.
79. Schlesinger RW (1950). Incomplete growth cycle of influenza virus in mouse brain. Proc Soc Exp Biol Med 74: 541-548.
80. Schlesinger RW (1953). The relation of functionally deficient forms of influenza to viral development. Cold Spring Harbour Symp Quant Biol XVIII: 55-59.
81. Schlesinger RW, Bradshaw GL, Barbone F, Reinacher M, Rott R, Husak P (1989). Role of haemagglutinin cleavage and expression of M1 protein in replication of A/WS/33, A/PR/8/34, and WSN influenza viruses in mouse brain. J Virol 63: 1695-1703.
82. Scholtissek C, Vallbracht A, Flehmig B, Rott R (1979). Correlation of pathogenicity and gene constellation of influenza A viruses. II. Highly neurovirulent recombinants derived from non-neurovirulent or weakly neurovirulent parent virus strains. Virology 95: 492-500.
83. Schulman JL, Palese P (1977). Virulence factors of influenza A virus. WSN virus neuraminidase required for plaque production in MDBK cells. J Virol 24: 170-176.
84. Seto JT, Rott R (1966). Functional significance of sialidase during influenza virus multiplication. Virology 30: 731-737.
85. Skehel JJ, Bayley PM, Brown EB, Martin SR, Waterfield MD, White JM, Wilson IA, Wiley DC (1982). Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci USA 79: 968-972.
86. Smeenk CA, Brown EG (1994). The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J Virol 68: 530-534.
87. Smith GL, Hay AJ (1982). Replication of the influenza virus genome. Virology 118: 96-108.
88. Smith WC, Andrewes CH, Laidlaw PP (1933). A virus obtained from influenza patients. Lancet i: 66-68.
89. Snyder MH, London WT, Masaab HF, Chanock RM, Murphy BR (1990). A 36 nucleotide deletion mutation in the coding region of the NS1 gene of an influenza A virus RNA segment 8 specifies a temperature-dependent host-range phenotype. Virus Res 15: 69-83.
90. Stieneke-Gröber A, Vey M, Angliker H, Shaw E, Thomas G, Roberts C, Klenk HD, Garten W (1992). Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J 11: 2407-2414.
91. Stuart-Harris CH (1939). A neutropic strain of human influenza virus. Lancet i: 497-499.
92. Sugiura A (1975). Influenza virus genetics. In: The Influenza Viruses. Kilbourne ED (ed). pp. 171-213. Academic Press: New York.
93. Sugiura A, Tateno I, Kitamoto O (1958). Cerebral involvement of influenza. Report of three indicative cases. Jpn J Exp Med 28: 337-344.
94. Sugiura A, Ueda M (1980). Neurovirulence of influenza virus in mice. I. Neurovirutence of recombinants between virulent and avirulent virus strains. Virology 101: 440-449.
95. Sugrue RJ, Bahadur G, Zambon MC, Hall-Smith M, Douglas AR, Hay AJ (1990). Specific structural alteration of the influenza virus haemagglutinin by amantadine. EMBO J 9: 3469-3476.
96. Thraenhart O, Schley G, Kuwert E (1975). Isolation of influenza virus A/Hong Kong/1/68 (H3N2) from liquor cerebrospinalis of patients with CNS involvement. Med Klin 70: 1910-1914.
97. Tyrrell DAJ, Cameron AH (1957). The pathogenicity of influenza viruses for suckling mice. J Pathol Bacteriol 74: 37-48.
98. Valcárel J, Fortes P, Ortin J (1993). Splicing of influenza virus matrix protein mRNA expressed from a simian virus 40 recombinant. J Gen Virol 74: 1317-1326.
99. Vallbracht A, Flehmig B, Gerth HJ (1979). Influenza virus: appearance of high mouse-neurovirulent recombinants. Intervirology 11: 16-22.
100. Vallbracht A, Scholtissek C, Flehmig B, Gerth HJ (1980). Recombination of influenza A strains with Fowl Plague Virus can change pneumotropism for mice to a generalised infection with involvement of the central nervous system. Virology 107: 452-460.
101. Villarete L, Somasundaram T, Ahmed R (1994). Tissue-mediated selection of viral variants: correlation between glycoprotein mutation and growth in neuronal cells. J Virol 68: 7490-7496.
102. Wagner RR (1955). A pantropic strain of influenza virus: generalised infection and viremia in the infant mouse. Virology 1: 497-515.
103. Ward AC (1995a). Changes in the neuraminidase of neurovirulent influenza virus strains. Virus Genes 10: 253-260.
104. 1 protein during adaptation of influenza virus to mouse. Arch Virol 140: 383-389.
105. Ward AC, Azad AA, Macreadie IG, McKimm-Breschkin JL (1993). Complete nucleotide sequence of the non-structural gene of the human influenza virus strain A/ WS/33. Nucleic Acids Res 21: 2257.
106. Ward AC, Azad AA, McKimm-Breschkin JL (1995a). Changes in the NS gene of neurovirulent strains of influenza affect splicing. Virus Genes 10: 91-94.
107. Ward AC, Castelli LA, Lucantoni AC, White JF, Azad AA, Macreadie IG (1995b). Expression and analysis of the NS2 protein of influenza A virus. Arch Virol 140: 2067-2073.
108. Ward AC, de Koning-Ward TF (1995). Changes in the haemagglutinin gene of the neurovirulent strain A/ NWS/33. Virus Genes 10: 179-183.
109. Webster RG, Hinshaw VS, Bean WJ, van Wyke KL, Aubin DJS, Petersson G (1981). Characterization of an influenza A virus from seals. Virology 113: 712-724.
110. Weis W, Brown JH, Cusaek S, Paulson JC, Skehel JJ, Wiley DC (1988). Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333: 426-431.
111. Wharton SA (1987). The role of influenza virus haemagglutinin in membrane fusion. Microbiol Sci 4: 119-124.
112. Wharton SA, Weis W, Skehel JJ, Wiley DC (1989). Structure, function, and antigenicity of the hemagglutinin of influenza virus. In: The Influenza Viruses. Krug RM (ed). pp. 153-218. Plenum Press: New York.
113. Wiley DC, Skehel JJ (1987). The structure and function of the Hemagglutinin membrane glycoprotein of influenza virus. Ann Rev Biochem 56: 365-394.
114. Wilson IA, Skehel JJ, Wiley DC (1981). The hemagglutinin membrane glycoprotein of influenza virus, structure at 3 Å resolution. Nature 289: 366-373.
115. Winter G, Fields S, Brownlee GG (1981). Nucleotide sequence of the haemagglutinin of a human influenza virus H1 subtype. Nature 292: 72-75.
116. Yamamoto F, Maeno K, Shibata S, Iinuma M, Mryama A, Kawamoto Y (1987). Inactivation of influenza B virus by normal guinea-pig serum. J Gen Virol 68: 1135-1141.
117. Yasuda J, Nakada S, Kato A, Toyoda T, Ishihama A (1993a). Molecular assembly of influenza virus: association of the NS2 protein with virion matrix. Virology 196: 249-255.
118. Yasuda J, Toyoba T, Nakayama M, Ishihama A (1993b). Regulatory effects of matrix protein variations on influenza virus growth. Arch Virol 133: 282-294.
119. Ye Z, Baylor NW, Wagner RR (1989). Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with antiidiotypic antibodies and synthetic peptides. J Virol 63: 3586-3594.
120. Ye Z, Pal R, Fox JW, Wagner RR (1987). Functional and antigenic domains of the matrix (M1) protein of influenza A virus. J Virol 61: 239-246.
121. Zebedee SL, Lamb RA (1989a). Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein. Proc Natl Acad Sci USA 86: 1061-1065.
122. Zebedee SL, Lamb RA (1989b). Nucleotide sequence of influenza A virus RNA segment 7, a comparison of 5 isolates. Nucleic Acids Res 17: 2870.